145 related articles for article (PubMed ID: 16078389)
1. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
Lee JY; Kim BC; Park SG
J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
[TBL] [Abstract][Full Text] [Related]
2. Assessment of bioequivalence using a multiplicative model.
Chow SC; Peace KE; Shao J
J Biopharm Stat; 1991; 1(2):193-203. PubMed ID: 1844696
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence and intrasubject variability.
Liu JP
J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
[TBL] [Abstract][Full Text] [Related]
4. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
Chen YI; Huang CS
Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
[TBL] [Abstract][Full Text] [Related]
5. On assessment of bioequivalence under a higher-order crossover design.
Chow SC; Liu JP
J Biopharm Stat; 1992; 2(2):239-56. PubMed ID: 1300216
[TBL] [Abstract][Full Text] [Related]
6. The assessment of individual and population bioequivalence.
Chinchilli VM
J Biopharm Stat; 1996 Mar; 6(1):1-14. PubMed ID: 8838775
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
8. Analysis of multiple-dose bioequivalence studies.
Chinchilli VM; Esinhart JD; Barr WH
J Biopharm Stat; 1994 Nov; 4(3):423-35. PubMed ID: 7881454
[TBL] [Abstract][Full Text] [Related]
9. Effect of length of sampling schedule and washout interval on magnitude of drug carryover from period 1 to period 2 in two-period, two-treatment bioequivalence studies and its attendant effects on determination of bioequivalence.
Dhariwal K; Jackson A
Biopharm Drug Dispos; 2003 Jul; 24(5):219-28. PubMed ID: 12784322
[TBL] [Abstract][Full Text] [Related]
10. Assessment of individual bioequivalence using sufficient bootstrap procedure.
Beyaztas U
Pharm Stat; 2019 May; 18(3):388-398. PubMed ID: 30661295
[TBL] [Abstract][Full Text] [Related]
11. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
[TBL] [Abstract][Full Text] [Related]
12. Robust and bootstrap testing procedures for bioequivalence.
Shen CF; Iglewicz B
J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
[TBL] [Abstract][Full Text] [Related]
13. A two one-sided tests procedure for assessment of individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
[TBL] [Abstract][Full Text] [Related]
14. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
Panhard X; Mentré F
Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
Lui KJ
J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
[TBL] [Abstract][Full Text] [Related]
17. A three-step procedure for assessing bioequivalence in the general mixed model framework.
Vuorinen J; Turunen J
Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
[TBL] [Abstract][Full Text] [Related]
18. Viewpoint: observations on scaled average bioequivalence.
Patterson SD; Jones B
Pharm Stat; 2012; 11(1):1-7. PubMed ID: 22162308
[TBL] [Abstract][Full Text] [Related]
19. Use of Bayesian methods for multivariate bioequivalence measures.
Molina de Souza R; Achcar JA; Martinez EZ
J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466
[TBL] [Abstract][Full Text] [Related]
20. Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.
Correa JA; Bellavance F
Stat Med; 2001 Apr; 20(8):1185-96. PubMed ID: 11304735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
